OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Cisplatin Nanoparticles Promote Intratumoral CD8+ T Cell Priming via Antigen Presentation and T Cell Receptor Crosstalk
Haochen Yao, Na Shen, Guofeng Ji, et al.
Nano Letters (2022) Vol. 22, Iss. 8, pp. 3328-3339
Closed Access | Times Cited: 25

Showing 25 citing articles:

Enhancing the therapeutic efficacy of nanoparticles for cancer treatment using versatile targeted strategies
Hailong Tian, Tingting Zhang, Siyuan Qin, et al.
Journal of Hematology & Oncology (2022) Vol. 15, Iss. 1
Open Access | Times Cited: 243

Nanoparticles in tumor microenvironment remodeling and cancer immunotherapy
Qiang Lü, Dongquan Kou, Shenghan Lou, et al.
Journal of Hematology & Oncology (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 131

TME-Related Biomimetic Strategies Against Cancer
Cheng Peng, Yilin Xu, Jing Wu, et al.
International Journal of Nanomedicine (2024) Vol. Volume 19, pp. 109-135
Open Access | Times Cited: 28

Azide‐Masked Resiquimod Activated by Hypoxia for Selective Tumor Therapy
Jiali Sun, Zhilin Liu, Haochen Yao, et al.
Advanced Materials (2023) Vol. 35, Iss. 29
Closed Access | Times Cited: 32

Enhancing cell pyroptosis with biomimetic nanoparticles for melanoma chemo-immunotherapy
Shiquan Sun, Yong He, Jiaqi Xu, et al.
Journal of Controlled Release (2024) Vol. 367, pp. 470-485
Closed Access | Times Cited: 13

Targeting anticancer immunity in oral cancer: Drugs, products, and nanoparticles
Liling Qin, Jianan Wu
Environmental Research (2023) Vol. 239, pp. 116751-116751
Closed Access | Times Cited: 20

Biomimetic inducer enabled dual ferroptosis of tumor and M2-type macrophages for enhanced tumor immunotherapy
Mingqi Chen, Yucui Shen, Yinying Pu, et al.
Biomaterials (2023) Vol. 303, pp. 122386-122386
Closed Access | Times Cited: 19

Biomimetic Sealing of Cisplatin by Cancer Cell Membranes to Achieve Nucleophile Resistance and Tumor Targeting for Improved Cancer Therapy
Yu Xia, Ziyang Wang, Ze‐Nan Zhuang, et al.
ACS Applied Materials & Interfaces (2025)
Closed Access

The diverse effects of cisplatin on tumor microenvironment: Insights and challenges for the delivery of cisplatin by nanoparticles
Xinxin Meng, Feng‐Yun Ma, Dingli Yu
Environmental Research (2023) Vol. 240, pp. 117362-117362
Closed Access | Times Cited: 10

Site-specific delivery of cisplatin and paclitaxel mediated by liposomes: A promising approach in cancer chemotherapy
Jianyong Zou
Environmental Research (2023) Vol. 238, pp. 117111-117111
Closed Access | Times Cited: 9

ROS-responsive TLR7/8 nanoagonist and ultrasound modulate dendritic cells antigen presentation
Xitong Ren, Haochen Yao, Jiali Sun, et al.
Nano Today (2024) Vol. 57, pp. 102402-102402
Closed Access | Times Cited: 3

Nanoparticles for Coronavirus Control
Maryam Kianpour, Mohsen Akbarian, Vladimir N. Uversky
Nanomaterials (2022) Vol. 12, Iss. 9, pp. 1602-1602
Open Access | Times Cited: 14

Enhanced Sensitivity of Tumor Cells to Autophagy Inhibitors Using Fasting-Mimicking Diet and Targeted Lysosomal Delivery Nanoplatform
Ruihao Qian, Guoliang Cao, Wen Su, et al.
Nano Letters (2022) Vol. 22, Iss. 22, pp. 9154-9162
Closed Access | Times Cited: 13

Orchestrating cancer therapy: Recent advances in nanoplatforms harmonize immunotherapy with multifaceted treatments
Rongwei Xu, Pei Lin, Jiarong Zheng, et al.
Materials Today Bio (2024) Vol. 30, pp. 101386-101386
Closed Access | Times Cited: 2

Pemetrexed–Poly(salicylic acid) Assemblies Reshape Immunosuppressive Tumor Microenvironment for Enhanced Chemo-immunotherapy
Kai Sun, Jiaying Yu, Jinzhong Hu, et al.
ACS Materials Letters (2023) Vol. 5, Iss. 6, pp. 1581-1592
Closed Access | Times Cited: 4

Polymeric PD1/PDL1 Bispecific Antibody Enhances Immune Checkpoint Blockade Therapy
Fuxin Xue, Xitong Ren, Chaoying Kong, et al.
Materials Today Bio (2024) Vol. 28, pp. 101239-101239
Open Access | Times Cited: 1

Effect of neoadjuvant chemotherapy on the immune microenvironment of gynaecological tumours
Jing Xue, Yan Xia, Qin Ding, et al.
Annals of Medicine (2023) Vol. 55, Iss. 2
Open Access | Times Cited: 3

Recent Trends and Opportunities for the Targeted Immuno-Nanomaterials for Cancer Theranostics Applications
Clyde John, Kaahini Jain, Hema Brindha Masanam, et al.
Micromachines (2022) Vol. 13, Iss. 12, pp. 2217-2217
Open Access | Times Cited: 5

Poly(L-glutamic acid) based composites for improved dual immune checkpoint blockade therapy
Fuxin Xue, Haochen Yao, Jiali Sun, et al.
Research Square (Research Square) (2024)
Open Access

Boosting antitumor immunity in breast cancers: Potential of adjuvants, drugs, and nanocarriers
Ping Chen, Lei Ren, Youwei Guo, et al.
International Reviews of Immunology (2024), pp. 1-24
Closed Access

Effects of Tolerant Nanoparticles Loaded with Various Regulatory Molecules on the Development of Experimental Autoimmune Encephalomyelitis
Weiwei Liang, Lin Cong, Hongmei Yu
Science of Advanced Materials (2023) Vol. 15, Iss. 7, pp. 926-935
Closed Access

Page 1

Scroll to top